Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies (Q57226425)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

article

Language	Label	Description	Also known as
English	Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

based on heuristic

inferred from title

0 references

Alexandra Trkola

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Huldrych F Günthard

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Annette Oxenius

10

object named as

Annette Oxenius

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Peter Rusert

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Beda Joos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Marek Fischer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Christine Leemann

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Amapola Manrique

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Rainer Weber

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Gabriela Stiegler

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Brigitta Vcelar

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Hermann Katinger

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Leonardo Aceto

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

0 references

publication date

8 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

615-622

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Immunopathogenesis and immunotherapy in AIDS virus infections

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Role of neutralizing antibodies in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Present status of human HIV vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Phase I Study of a Human Monoclonal Antibody Directed against the CD4-Binding Site of HIV Type 1 Glycoprotein 120

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

21 January 2018

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of HIV-1 neutralization escape mutants

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of low HIV-1 RNA levels in plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM1244

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

ResearchGate publication ID

0 references

Semantic Scholar corpus ID

0 references

Semantic Scholar paper ID

61b8c7fb21c0c76686c912c9fde4d98c53e7d4b9

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57226425&oldid=2213365212"